Nibbs R J, Wylie S M, Pragnell I B, Graham G J
Cancer Research Campaign Laboratories, The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, United Kingdom.
J Biol Chem. 1997 May 9;272(19):12495-504. doi: 10.1074/jbc.272.19.12495.
The beta-chemokine macrophage inflammatory protein-1alpha (MIP-1alpha) is chemotactic for many hemopoietic cell types and can inhibit hemopoietic stem cell (HSC) proliferation, effects mediated through G-protein coupled heptahelical receptors. We have isolated cDNAs for seven chemokine receptors, CCR-1 to -5, MIP-1alphaRL1, and a novel cDNA, D6. Chinese hamster ovary cells expressing CCR-1, -3, -5, and D6 bound 125I-murine MIP-1alpha: the order of affinity was D6 > CCR-5 > CCR-1 > CCR-3. Each bound a distinct subset of other beta-chemokines: the order of competition for 125I-murine MIP-1alpha on D6 was murine MIP-1alpha > human and murine MIP-1beta > human RANTES approximately JE > human MCP-3 > human MCP-1. Human MIP-1alpha and the alpha-chemokines did not compete. Like other chemokine receptors, D6 induced transient increases in [Ca2+] in HEK 293 cells upon ligand binding. D6 mRNA was abundant in lung and detectable in many other tissues. Bone marrow cell fractionation demonstrated T-cell and macrophage/monocyte expression of D6, and CCR-1, -3, and -5. Moreover, we could detect expression of CCR-3, CCR-5, and to a greater extent D6 in a cell population enriched for HSCs. Thus, we have characterized four murine beta chemokine receptors that are likely involved in mediating the pro-inflammatory functions of MIP-1alpha and other chemokines, and we present D6, CCR-3, and CCR-5 as candidate receptors in MIP-1alpha-induced HSC inhibition.
β趋化因子巨噬细胞炎性蛋白-1α(MIP-1α)对多种造血细胞类型具有趋化作用,并可抑制造血干细胞(HSC)增殖,这些效应是通过G蛋白偶联的七螺旋受体介导的。我们已经分离出了7种趋化因子受体的cDNA,即CCR-1至-5、MIP-1αRL1,以及一个新的cDNA,D6。表达CCR-1、-3、-5和D6的中国仓鼠卵巢细胞可结合125I-鼠源MIP-1α:亲和力顺序为D6 > CCR-5 > CCR-1 > CCR-3。每种受体结合其他β趋化因子的不同亚群:D6上125I-鼠源MIP-1α的竞争顺序为鼠源MIP-1α > 人源和鼠源MIP-1β > 人源RANTES约等于JE > 人源MCP-3 > 人源MCP-1。人源MIP-1α和α趋化因子不参与竞争。与其他趋化因子受体一样,D6在配体结合后可诱导HEK 293细胞中[Ca2+]短暂升高。D6 mRNA在肺中含量丰富,在许多其他组织中也可检测到。骨髓细胞分级分离显示D6以及CCR-1、-3和-5在T细胞和巨噬细胞/单核细胞中表达。此外,我们在富含HSC的细胞群体中检测到了CCR-3、CCR-5以及程度更高的D6的表达。因此,我们已经鉴定出四种鼠源β趋化因子受体,它们可能参与介导MIP-1α和其他趋化因子的促炎功能,并且我们提出D6、CCR-3和CCR-5作为MIP-1α诱导的HSC抑制中的候选受体。